Cardinal Health (NYSE: CAH) lifts 2026 EPS outlook as non-GAAP Q3 profits surge

Cardinal Health reported robust third-quarter fiscal 2026 results, with non-GAAP diluted EPS soaring 35% to $3.17 and revenue increasing 11% to $60.9 billion. Despite a GAAP diluted EPS decline of 20% due to a $184 million goodwill impairment charge, the company raised its fiscal 2026 non-GAAP EPS outlook to $10.70-$10.80 and adjusted free cash flow guidance to $3.3-$3.7 billion, driven by strong operational performance and strategic capital allocation including debt reduction and share repurchases.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin